Provided by Tiger Trade Technology Pte. Ltd.

Fate Therapeutics

2.32
+0.02000.87%
Post-market: 2.340.0161+0.69%19:30 EDT
Volume:658.02K
Turnover:1.52M
Market Cap:278.40M
PE:-2.20
High:2.36
Open:2.34
Low:2.27
Close:2.30
52wk High:3.23
52wk Low:0.9500
Shares:120.00M
Float Shares:104.94M
Volume Ratio:0.42
T/O Rate:0.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0528
EPS(LYR):-1.1500
ROE:-60.75%
ROA:-26.22%
PB:1.81
PE(LYR):-2.02

Loading ...

Feb 28, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 13, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 05, 2023

Major Issues Report

8-K - Current report
Nov 07, 2022

Major Issues Report

8-K - Current report
Nov 03, 2022

Major Issues Report

8-K - Current report
Nov 03, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 03, 2022

Major Issues Report

8-K - Current report
Aug 03, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 30, 2022

Major Issues Report

8-K - Current report
Jun 13, 2022

Major Issues Report

8-K - Current report
Jun 09, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
May 04, 2022

Major Issues Report

8-K - Current report
May 04, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 28, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 28, 2022

Major Issues Report

8-K - Current report
Feb 28, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 10, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 14, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities